22h
News Medical on MSNSotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial showsSotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Valentine’s Day has come and gone, but it’s never too late to focus on your heart health. A groundbreaking new study ...
Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Knowledge is power when it comes to your heart health. Getting to know your numbers is one of the most important steps in ...
The Senior Consultant in Internal Medicine, said: “I conducted a study on red wine and found that one glass of red wine a day ...
The natural process of aging brings significant changes to every woman's body, but Black women face unique challenges when it ...
Ultra-processed foods (UPFs) have become the latest villain in our never-ending search for an easy scapegoat. But before we ...
For days, she dealt with the nagging pain. One day, she and her daughter went to the mall, and Caprario decided to run up and down the stairs to try and relieve the discomfort. On other days, she ...
THE Healthy Philippines Alliance (HPA) on Saturday reminded Filipinos to avoid unhealthy fat consumption this Philippine Heart Month.
Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results